A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Roundup: Morocco steal limelight on day of World Cup drama
Chasing perfection in Paris preparations
Friendly visa policies to help boost tourism
Lynn Williams breaks NWSL goal
Enterprises bullish on supply chain expo
Xi Says BRICS Important Force in Shaping Int'l Landscape
Argentina wins friendly match as fans give warmest of welcomes in Beijing
Devout Christian doctor, 68, who punched dementia
NPPA says it approves 105 home
The fightback begins: Boss of London's Queen Mary University tells pro
Beijing 2022 innovates green standard for snow venues